Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Renflexis

×

Overview

What is Renflexis?

Infliximab-abda, the active ingredient in RENFLEXIS, is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα). It has a molecular weight of approximately 149.1 kilodaltons. Infliximab-abda is produced by a recombinant cell line cultured and is purified by a series of steps that includes measures to inactivate and remove viruses.

RENFLEXIS (infliximab-abda) for Injection is supplied as a sterile, white, lyophilized powder for intravenous infusion. Following reconstitution with 10 mL of Sterile Water for Injection, USP, the resulting pH is approximately 6. Each mL contains 10 mg infliximab-abda, dibasic sodium phosphate heptahydrate (0.12 mg), monobasic sodium phosphate monohydrate (0.63 mg), polysorbate 80 (0.05 mg), and sucrose (50 mg). No preservatives are present.



What does Renflexis look like?



What are the available doses of Renflexis?

For injection: 100 mg of lyophilized infliximab-abda in a 20 mL vial for intravenous infusion. ()

What should I talk to my health care provider before I take Renflexis?

How should I use Renflexis?

RENFLEXIS is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy.

RENFLEXIS is indicated for reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing Crohn's disease.

The recommended dose of RENFLEXIS is 5 mg/kg given as an intravenous induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 5 mg/kg every 8 weeks thereafter for the treatment of adults with moderately to severely active Crohn's disease or fistulizing Crohn's disease. For adult patients who respond and then lose their response, consideration may be given to treatment with 10 mg/kg. Patients who do not respond by Week 14 are unlikely to respond with continued dosing and consideration should be given to discontinue RENFLEXIS in these patients.


What interacts with Renflexis?

Sorry No Records found


What are the warnings of Renflexis?

Sorry No Records found


What are the precautions of Renflexis?

Sorry No Records found


What are the side effects of Renflexis?

Sorry No records found


What should I look out for while using Renflexis?

RENFLEXIS at doses > 5 mg/kg should not be administered to patients with moderate to severe heart failure. In a randomized study evaluating infliximab in patients with moderate to severe heart failure (New York Heart Association [NYHA] Functional Class III/IV), infliximab treatment at 10 mg/kg was associated with an increased incidence of death and hospitalization due to worsening heart failure .

RENFLEXIS should not be re-administered to patients who have experienced a severe hypersensitivity reaction to infliximab products. Additionally, RENFLEXIS should not be administered to patients with known hypersensitivity to inactive components of the product or to any murine proteins.


What might happen if I take too much Renflexis?

Single doses up to 20 mg/kg of infliximab have been administered without any direct toxic effect. In case of overdosage, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions or effects and appropriate symptomatic treatment instituted immediately.


How should I store and handle Renflexis?

Store between 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature].Each RENFLEXIS (infliximab-abda) for Injection 100 mg vial is individually packaged in a carton.Each single dose vial contains 100 mg of lyophilized infliximab-abda for final reconstitution volume of 10 mL.Each RENFLEXIS (infliximab-abda) for Injection 100 mg vial is individually packaged in a carton.Each single dose vial contains 100 mg of lyophilized infliximab-abda for final reconstitution volume of 10 mL.